outcomes
For decades, breast cancer has been classified as HER2 positive or HER2 negative. However, in 2019, research began to emerge showing promising results in breast cancers with low levels of HER2, for which there were no approved therapies.
By: Kellie Beumer; Melissa Kelly, PhD; Joseph Kim, MD, MPH, MBA, FACEHP, CPHQ; Jim Mortimer; and Kevin Obholz, PhD
leadership
Do you have a burning question for someone in the grantor space, or are you in need of an answer to a frequently asked, grant-related question? Check out part 4 of the Almanac series, “Ask the Grantor.”
outcomes
We hypothesized that CE based in knowledge acquisition (the independent variable) can directly impact practice change (the dependent variable) if designed with probing motivational decision science material.
By: John Ruggiero, PhD, MPA, Antonio B. Meo, CHCP, M. Theresa Bishay, PharmD, Brigitte Azzi, PharmD, Osarumen Urhoghide, PharmD, and Gail Malnarick
outcomes
We hypothesized that CE based in knowledge acquisition (the independent variable) can directly impact practice change (the dependent variable) if designed with probing motivational decision science material.
By: John Ruggiero, PhD, MPA, Antonio B. Meo, CHCP, M. Theresa Bishay, PharmD, Brigitte Azzi, PharmD, Osarumen Urhoghide, PharmD, and Gail Malnarick
leadership
Do you have a burning question for someone in the grantor space, or are you in need of an answer to a frequently asked, grant-related question? Check out part 3 of the new Almanac series, “Ask the Grantor.”
outcomes
In this Q+A, Jim Palatine, RPh, MBA talks with panelists Karyn Ruiz-Cordell, MA, PhD, and Kate Biles, CHC on ‘Reframing the Dialogue to Achieve NextGen Outcomes Reports.’
By: Moderator: Jim Palatine, RPh, MBA; Panelists: Karyn Ruiz-Cordell, MA, PhD; Kate Biles, CHCP
leadership
Do you have a burning question for someone in the grantor space, or are you in need of an answer to a frequently asked, grant-related question? The Almanac is excited to share part 2 of the new series, “Ask the Grantor.” This new...
outcomes
To support broad initiatives to improve the health of the public through the education of healthcare providers and patients, the Alliance and Pfizer partnered to create project opportunities focused on increasing immunization rates of adults aged...
By: An Alliance and Pfizer Partnership
leadership
Do you have a burning question for someone in the grantor space, or are you in need of an answer to a frequently asked, grant-related question? The Almanac is excited to launch a new series, “Ask the Grantor.” This new series, created...